Chairperson’s Closing Comments and Vision Statement - The Evolving Therapeutic Roadmap for Atopic Dermatitis: The Foundation Role of Targeting Cytokine Signaling Systems in Patients with Moderate-to- Severe AD: Evidence for a Paradigm Shift for Optimizing Treatment Outcomes in Patients with AP - Thomas Bieber, MD, PhD, MDRA – Program Chair

Chairperson’s Closing Comments and Vision Statement - The Evolving Therapeutic Roadmap for Atopic Dermatitis: The Foundation Role of Targeting Cytokine Signaling Systems in Patients with Moderate-to- Severe AD: Evidence for a Paradigm Shift for Optimizing Treatment Outcomes in Patients with AP - Thomas Bieber, MD, PhD, MDRA – Program Chair


Published

October 30, 2015

Created by

CMEducation Resources symposium